Analyst Ratings for PTC Therapeutics (PTCT) [Sells]
PTCT Rating Summary
PTCT Price Target Summary
- Highest: $73.00 (Cantor Fitzgerald)
- Lowest: $17.00 (Citi)
- Average: $34.21
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$34.21 (+35%)
* Over Last 12-Mos
Rating Score: 3.6 / 10
Percentile Rank: 34%
Avg. $ Target:
$34.21 (+35%)
* Over Last 12-Mos
Rating Score: 3.6 / 10
Percentile Rank: 34%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | Morgan Stanley | Jeffrey Hung | Downgrade | Underweight (Equalweight) |
28.00 (N/A) |
28.39 (25.35) |
-10.71% | Details |
| 10/27/2023 | Citi | David Lebowitz | Downgrade | Sell (Neutral) |
17.00 (29.00) |
23.95 (25.35) |
5.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
